Published in Front Pharmacol on June 09, 2015
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis. Stem Cells Int (2016) 0.81
New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis. Biomed Res Int (2015) 0.79
Ezh2 restricts the smooth muscle lineage during mouse lung mesothelial development. Development (2016) 0.76
Transcriptomic Analysis of the Claudin Interactome in Malignant Pleural Mesothelioma: Evaluation of the Effect of Disease Phenotype, Asbestos Exposure, and CDKN2A Deletion Status. Front Physiol (2017) 0.75
A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential. Sci Rep (2016) 0.75
Lung carcinogenesis and fibrosis taken together: just coincidence? Curr Opin Pulm Med (2017) 0.75
Pharmacological HIF-inhibition attenuates postoperative adhesion formation. Sci Rep (2017) 0.75
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med (2014) 9.40
Biomarkers for epithelial-mesenchymal transitions. J Clin Invest (2009) 8.76
The myofibroblast: one function, multiple origins. Am J Pathol (2007) 8.64
Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature (2008) 7.03
A myocardial lineage derives from Tbx18 epicardial cells. Nature (2008) 6.15
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol (1989) 5.41
Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med (2003) 5.01
Mechanisms of pulmonary fibrosis. Annu Rev Med (2004) 4.37
The myofibroblast in pulmonary fibrosis. Chest (2002) 3.46
The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol (1991) 3.35
Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol (2002) 3.33
The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl) (2004) 3.32
TGFbeta signaling: receptors, transducers, and Mad proteins. Cell (1996) 3.31
The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development (2005) 3.07
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest (2000) 2.36
Idiopathic pulmonary fibrosis. Orphanet J Rare Dis (2008) 2.34
Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol (2005) 2.28
The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg Suppl (1997) 2.16
Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med (1992) 2.15
Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development. Proc Natl Acad Sci U S A (2008) 2.08
Causes and management of pleural fibrosis. Respirology (2004) 2.04
Prevention of intra-peritoneal adhesions in gynaecological surgery: theory and evidence. Reprod Biomed Online (2010) 2.03
Epicardial/Mesothelial cell line retains vasculogenic potential of embryonic epicardium. Circ Res (2003) 2.01
Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology (2011) 1.95
Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol (2007) 1.94
Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis. Hum Pathol (1980) 1.89
Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update (2001) 1.86
The molecular basis of asbestos induced lung injury. Thorax (1999) 1.82
Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol (2004) 1.81
Mesothelial cells: their structure, function and role in serosal repair. Respirology (2002) 1.73
Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int (1990) 1.71
Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int (2005) 1.67
Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Dev Biol (2009) 1.63
Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis. Nat Med (2015) 1.62
Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc Natl Acad Sci U S A (2013) 1.59
Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis (1991) 1.58
Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med (2002) 1.53
Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients. Nephrol Dial Transplant (2009) 1.51
Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent. Nephrol Dial Transplant (2012) 1.46
Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int (2000) 1.44
Intrapleural streptokinase in the treatment of haemothorax and empyema. Scand J Thorac Cardiovasc Surg (1977) 1.43
Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells (2006) 1.42
Adhesive small bowel obstruction: epidemiology, biology and prevention. Can J Surg (2007) 1.39
Effects of human adipose-derived stem cells on the regeneration of damaged visceral pleural mesothelial cells: a morphological study in a rabbit model. Interact Cardiovasc Thorac Surg (2014) 1.39
Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol (2013) 1.39
12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J Immunol (2008) 1.38
The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest (1996) 1.38
TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol (2007) 1.36
Pulmonary toxicities from targeted therapies: a review. Target Oncol (2011) 1.28
Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol (2009) 1.27
Myofibroblastic conversion of mesothelial cells. Kidney Int (2003) 1.24
Intrinsic cells: mesothelial cells -- central players in regulating inflammation and resolution. Perit Dial Int (2009) 1.19
Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway. Dis Model Mech (2008) 1.18
Pathophysiology of the pleura. Respiration (2008) 1.17
Formation and prevention of postoperative abdominal adhesions. J Surg Res (2006) 1.16
Pathogenesis of pleural fibrosis. Respirology (2004) 1.16
Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol (1992) 1.15
Smad3-dependent and -independent pathways are involved in peritoneal membrane injury. Kidney Int (2009) 1.15
Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J Immunol (2004) 1.14
Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest (2003) 1.13
The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability. Am J Physiol Lung Cell Mol Physiol (2008) 1.11
Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6. PLoS One (2012) 1.11
Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med (1997) 1.10
Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int (2008) 1.09
Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int (2003) 1.08
Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans (2002) 1.07
Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med (1995) 1.07
Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol Med (2012) 1.07
Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol (2001) 1.06
Derivation of lung mesenchymal lineages from the fetal mesothelium requires hedgehog signaling for mesothelial cell entry. Development (2013) 1.06
Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: pre-clinical studies. Hum Reprod (2000) 1.05
Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol (2002) 1.04
Serosal mesothelium retains vasculogenic potential. Dev Dyn (2007) 1.04
Prevention of postsurgical tissue adhesion by anti-inflammatory drug-loaded pluronic mixtures with sol-gel transition behavior. J Biomed Mater Res A (2005) 1.03
Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol (2000) 1.01
Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant (2006) 1.01
The pathogenesis of pleural space loculation and fibrosis. Curr Opin Pulm Med (2008) 1.01
Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Mediators Inflamm (2012) 1.00
Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci (2002) 1.00
Structure and function of mesothelial cells. Cancer Treat Res (2007) 1.00
Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling. Kidney Int (2013) 0.99
Effects of dexamethasone on the TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells. Lab Invest (2012) 0.97
Lysis of plasma clots by urokinase-soluble urokinase receptor complexes. Blood (1998) 0.97
Adhesion-related complications are common, but rarely discussed in preoperative consent: a multicenter study. World J Surg (2009) 0.97
Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am J Physiol (1995) 0.96
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab Invest (2010) 0.96
Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious. Perit Dial Int (2005) 0.96
Reduction of postsurgical adhesions in a rat model: a comparative study. Clinics (Sao Paulo) (2009) 0.96
Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl (2003) 0.96
Prevention of postoperative adhesions by tissue-type plasminogen activator (t-PA) in the rabbit. Eur J Obstet Gynecol Reprod Biol (1990) 0.96
Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta). Thromb Haemost (1998) 0.95
miR-30a negatively regulates TGF-β1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1. Am J Pathol (2013) 0.94
Experimental manipulation of transforming growth factor-beta isoforms significantly affects adhesion formation in a murine surgical model. Am J Pathol (2005) 0.94
Tissue anti-adhesion potential of ibuprofen-loaded PLLA-PEG diblock copolymer films. Biomaterials (2005) 0.94
Mechanisms and interventions in peritoneal fibrosis. Clin Exp Nephrol (2011) 0.93
TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis. J Am Soc Nephrol (2013) 0.93